Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 1
2003 2
2004 2
2005 1
2006 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.
Dannenberg AJ, Subbaramaiah K. Dannenberg AJ, et al. Cancer Cell. 2003 Dec;4(6):431-6. doi: 10.1016/s1535-6108(03)00310-6. Cancer Cell. 2003. PMID: 14706335 Free article. Review. No abstract available.
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K. Dannenberg AJ, et al. Lancet Oncol. 2001 Sep;2(9):544-51. doi: 10.1016/S1470-2045(01)00488-0. Lancet Oncol. 2001. PMID: 11905709 Review.
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
Subbaramaiah K, Dannenberg AJ. Subbaramaiah K, et al. Trends Pharmacol Sci. 2003 Feb;24(2):96-102. doi: 10.1016/S0165-6147(02)00043-3. Trends Pharmacol Sci. 2003. PMID: 12559775 Review.
Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression.
Khan KM, Howe LR, Falcone DJ. Khan KM, et al. J Biol Chem. 2004 May 21;279(21):22039-46. doi: 10.1074/jbc.M312735200. Epub 2004 Mar 15. J Biol Chem. 2004. PMID: 15024003 Free article.
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ. Howe LR, et al. Cancer Res. 2005 Nov 1;65(21):10113-9. doi: 10.1158/0008-5472.CAN-05-1524. Cancer Res. 2005. PMID: 16267038 Free article.
PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2.
Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM. Howe LR, et al. J Biol Chem. 2001 Jun 8;276(23):20108-15. doi: 10.1074/jbc.M010692200. Epub 2001 Mar 26. J Biol Chem. 2001. PMID: 11274170 Free article.
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.
Subbaramaiah K, Howe LR, Port ER, Brogi E, Fishman J, Liu CH, Hla T, Hudis C, Dannenberg AJ. Subbaramaiah K, et al. Cancer Res. 2006 May 15;66(10):5504-11. doi: 10.1158/0008-5472.CAN-05-4076. Cancer Res. 2006. PMID: 16707480 Free article.
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Terry MB, et al. JAMA. 2004 May 26;291(20):2433-40. doi: 10.1001/jama.291.20.2433. JAMA. 2004. PMID: 15161893
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ. Howe LR, et al. Cancer Res. 2002 Oct 1;62(19):5405-7. Cancer Res. 2002. PMID: 12359744 Free article.
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
Subbaramaiah K, Lin DT, Hart JC, Dannenberg AJ. Subbaramaiah K, et al. J Biol Chem. 2001 Apr 13;276(15):12440-8. doi: 10.1074/jbc.M007237200. Epub 2001 Jan 23. J Biol Chem. 2001. PMID: 11278336 Free article. Retracted.
Feedback